Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Faculty Disclosure Statement
Dr Dunbar: Speakers' bureau: Kos, Pfizer; Dr Szapary: Grants/research support: Takeda; Speakers' bureau: Takeda, Pfizer; Dr Haffner: Reported no financial support; Dr Rader: Consultant/grants/research support: Abbott, AstraZeneca, Bristol-Myers Squibb, Fournier, Kos, Merck, Pfizer, Schering-Plough; Speakers' bureau: Abbott, AstraZeneca, Bristol-Myers Squibb, Kos, Merck, Pfizer, Schering-Plough.
This report includes discussion of insulin sensitizers, including metformin and the thiazolidinediones, for preventing type 2 0diabetes, an indication not currently approved by the FDA.
